(Q53189719)

12 May 2018

title

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. (English)

1 reference

12 May 2018

main subject

vascular calcification

1 reference

7

1 reference

12 May 2018

author name string

L Desjardins

1

1 reference

12 May 2018

S Liabeuf

2

1 reference

12 May 2018

C Renard

3

1 reference

12 May 2018

A Lenglet

4

1 reference

12 May 2018

H-D Lemke

5

1 reference

12 May 2018

G Choukroun

6

1 reference

12 May 2018

Z A Massy

8

1 reference

12 May 2018

European Uremic Toxin (EUTox) Work Group

9

1 reference

12 May 2018

language of work or name

English

0 references

publication date

23 November 2011

1 reference

12 May 2018

Osteoporosis International

published in

1 reference

12 May 2018

volume

23

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

page(s)

2017-2025

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00198-011-1838-0

exact match

0 references

cites work

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Chronic kidney disease as cause of cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Quantification of coronary artery calcium using ultrafast computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Genetic evidence of serum phosphate-independent functions of FGF-23 on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1838-0

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

21 January 2018

1 reference

12 December 2020

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice

1 reference

12 December 2020

Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness

1 reference

12 December 2020

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

12 December 2020

Klotho deficiency causes vascular calcification in chronic kidney disease

1 reference

12 December 2020

Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients

1 reference

12 December 2020

Total hip bone mass predicts survival in chronic hemodialysis patients

1 reference

12 December 2020

Pulse wave velocity and vascular calcification at different stages of chronic kidney disease

1 reference

12 December 2020

10.1007/S00198-011-1838-0

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018